FAB vs. COS, C4XD, DDDD, POLB, OKYO, SAR, SNG, AOR, AREC, and IMM
Should you be buying Fusion Antibodies stock or one of its competitors? The main competitors of Fusion Antibodies include Collagen Solutions plc (COS.L) (COS), C4X Discovery (C4XD), 4D pharma (DDDD), Poolbeg Pharma (POLB), OKYO Pharma (OKYO), Sareum (SAR), Synairgen (SNG), AorTech International (AOR), Arecor Therapeutics (AREC), and ImmuPharma (IMM). These companies are all part of the "biotechnology" industry.
Fusion Antibodies vs.
Collagen Solutions plc (COS.L) (LON:COS) and Fusion Antibodies (LON:FAB) are both small-cap medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, earnings, valuation, community ranking, profitability, risk and dividends.
In the previous week, Collagen Solutions plc (COS.L)'s average media sentiment score of 0.00 equaled Fusion Antibodies'average media sentiment score.
Collagen Solutions plc (COS.L) received 75 more outperform votes than Fusion Antibodies when rated by MarketBeat users. Likewise, 72.88% of users gave Collagen Solutions plc (COS.L) an outperform vote while only 68.35% of users gave Fusion Antibodies an outperform vote.
Collagen Solutions plc (COS.L) has a net margin of 0.00% compared to Fusion Antibodies' net margin of -195.95%. Collagen Solutions plc (COS.L)'s return on equity of 0.00% beat Fusion Antibodies' return on equity.
Collagen Solutions plc (COS.L) has higher revenue and earnings than Fusion Antibodies. Fusion Antibodies is trading at a lower price-to-earnings ratio than Collagen Solutions plc (COS.L), indicating that it is currently the more affordable of the two stocks.
21.0% of Fusion Antibodies shares are held by institutional investors. 11.4% of Fusion Antibodies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.
Summary
Collagen Solutions plc (COS.L) beats Fusion Antibodies on 7 of the 10 factors compared between the two stocks.
Get Fusion Antibodies News Delivered to You Automatically
Sign up to receive the latest news and ratings for FAB and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Fusion Antibodies Competitors List
Related Companies and Tools
This page (LON:FAB) was last updated on 2/22/2025 by MarketBeat.com Staff
